SCHEMBL5505116

SCHEMBL5505116

Cc1nn(C)c(SCC(=O)N[C@@H]2C(=O)N3C(C(=O)[O-])=C(/C=C4\CCN(C5CC5)C4=O)CS[C@H]23)nc1=O.[Na+]

nearest known ligand 0.41

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 12/20 0.41
MAPT P10636 11/20 0.41
HSD17B10 Q99714 7/20 0.41
CYP3A4 P08684 5/20 0.41
POLB P06746 5/20 0.41
KDM4E B2RXH2 4/20 0.41
APEX1 P27695 4/20 0.41
LMNA P02545 3/20 0.41
RECQL P46063 2/20 0.41
CYP2D6 P10635 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 3/20 0.38
BLM P54132 2/20 0.38
ABCC4 O15439 1/20 0.37
NFKB1 P19838 1/20 0.37
CA5A P35218 1/20 0.35
NR1I2 O75469 1/20 0.35
HPGD P15428 2/20 0.35
PTPN7 P35236 1/20 0.35
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5505123 0.93 CA5A (0.40) TDP1MAPTPOLBLMNAALDH1A1
SCHEMBL5505113 0.93 CA5A (0.40) TDP1MAPTPOLBLMNAALDH1A1
SCHEMBL5506565 0.87 TDP1 (0.47) TDP1MAPTHSD17B10CYP3A4POLB
SCHEMBL5505621 0.87 MAPT (0.44) TDP1MAPTHSD17B10CYP3A4POLB
SCHEMBL5507843 0.83 MEN1 (0.44) TDP1MAPTHSD17B10CYP3A4POLB
SCHEMBL5504460 0.82 TDP1 (0.44) TDP1MAPTHSD17B10CYP3A4POLB
SCHEMBL5507287 0.82 TDP1 (0.40) TDP1MAPTHSD17B10CYP3A4POLB
SCHEMBL5505829 0.82 TDP1 (0.41) TDP1MAPTHSD17B10CYP3A4POLB
SCHEMBL5506310 0.81 TDP1 (0.48) TDP1MAPTHSD17B10CYP3A4POLB
SCHEMBL5500857 0.81 TDP1 (0.49) TDP1MAPTHSD17B10CYP3A4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841339-B1 Vinylpyrrolidinon cephalosporin derivatives BASILEA PHARMACEUTICA AG (CH) 2007-02-21 EP disclosed
US-6294668-B1 ANTIBACTERIAL ACTIVITY AGAINST BETA-LACTAM SENSITIVE AND RESISTANT GRAM-POSITIVE BACTERIA, SUCH AS STAPHYLOCOCCI, PNEUMOCOCCI, AND ENTEROCOCCI; USED IN THERAPY OF INFECTIOUS DISEASES CAUSED BY THOSE BACTERIA HOFFMAN-LA ROCHE INC. 2001-09-25 US disclosed
EP-0841339-A1 Vinylpyrrolidinon cephalosporin derivatives F. HOFFMANN-LA ROCHE AG (CH) 1998-05-13 EP disclosed